COVID-19 vaccination for pregnant women: strategies for enhanced coverage

Authors

  • Jennifer Britto John Chettinad Hospital & Research Institute, Chettinad Academy of Research & Education, OMR- Kelambakkam, Chennai https://orcid.org/0000-0001-9541-6225
  • Vinoth Gnana Chellaiyan Devanbu Chettinad Hospital & Research Institute, Chettinad Academy of Research & Education, OMR- Kelambakkam, Chennai https://orcid.org/0000-0003-4652-3184
  • Vijayalakshmi Kandaswamy Chettinad Hospital & Research Institute, Chettinad Academy of Research & Education, OMR- Kelambakkam, Chennai https://orcid.org/0000-0002-6303-9231

DOI:

https://doi.org/10.47203/IJCH.2021.v33i03.025

Keywords:

COVID-19, Vaccination registry, Pregnant Women

Abstract

Following the recommendations from the National Technical Advisory Group (NTAG) on Immunization, the Government of India approved three vaccines – an inactivated vaccine, Covaxin and two non-replicating vector-based vaccines, Covishield and Sputnik V for restricted use in an emergency for pregnant women.(1)The late approval of vaccination of pregnant women was due to a lack of evidence, because pregnant women were excluded from previous COVID vaccination trials. The restricted use of this vaccine recommended by NTAG also complies with the regulations of the Centers for Disease Control and Prevention (CDC), the American College of Obstetricians and Gynecologists, and the American Academy of Pediatrics. (2-4)

Downloads

Download data is not yet available.

Published

2021-09-30

How to Cite

1.
John JB, Devanbu VGC, Kandaswamy V. COVID-19 vaccination for pregnant women: strategies for enhanced coverage. Indian J Community Health [Internet]. 2021 Sep. 30 [cited 2021 Dec. 5];33(3):539-40. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/2228

Issue

Section

Letter to Editor

Most read articles by the same author(s)